143 related articles for article (PubMed ID: 21256766)
1. Heart transplantation in children with markedly elevated pulmonary vascular resistance: impact of right ventricular failure on outcome.
Ofori-Amanfo G; Hsu D; Lamour JM; Mital S; O'Byrne ML; Smerling AJ; Chen JM; Mosca R; Addonizio LJ
J Heart Lung Transplant; 2011 Jun; 30(6):659-66. PubMed ID: 21256766
[TBL] [Abstract][Full Text] [Related]
2. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
[TBL] [Abstract][Full Text] [Related]
3. Acute right ventricular failure after pediatric cardiac transplant: predictors and long-term outcome in current era of transplantation medicine.
Hoskote A; Carter C; Rees P; Elliott M; Burch M; Brown K
J Thorac Cardiovasc Surg; 2010 Jan; 139(1):146-53. PubMed ID: 19910002
[TBL] [Abstract][Full Text] [Related]
4. [Inhalation nitric oxide during heart transplantation].
Kozlov IA; Poptsov VN
Anesteziol Reanimatol; 1999; (5):9-14. PubMed ID: 10560143
[TBL] [Abstract][Full Text] [Related]
5. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates.
Salzberg SP; Lachat ML; von Harbou K; Zünd G; Turina MI
Eur J Cardiothorac Surg; 2005 Feb; 27(2):222-5. PubMed ID: 15691674
[TBL] [Abstract][Full Text] [Related]
6. Preoperative pulmonary hemodynamics and assessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation?
Giglia TM; Humpl T
Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S57-69. PubMed ID: 20216166
[TBL] [Abstract][Full Text] [Related]
7. Heterotopic heart transplantation for elevated pulmonary vascular resistance in pediatric patients.
Cochrane AD; Adams DH; Radley-Smith R; Khaghani A; Yacoub MH
J Heart Lung Transplant; 1995; 14(2):296-301. PubMed ID: 7779849
[TBL] [Abstract][Full Text] [Related]
8. Effect of reversible pulmonary hypertension on outcomes after heart transplantation.
Drakos SG; Kfoury AG; Gilbert EM; Horne BD; Long JW; Stringham JC; Campbell BA; Renlund DG
J Heart Lung Transplant; 2007 Apr; 26(4):319-23. PubMed ID: 17403471
[TBL] [Abstract][Full Text] [Related]
9. Pneumatic pulsatile ventricular assist device as a bridge to heart transplantation in pediatric patients.
Amodeo A; Brancaccio G; Michielon G; Filippelli S; Ricci Z; Morelli S; Gagliardi MG; Iacobelli R; Pongiglione G; Di Donato RM
Artif Organs; 2010 Nov; 34(11):1017-22. PubMed ID: 21092045
[TBL] [Abstract][Full Text] [Related]
10. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
[TBL] [Abstract][Full Text] [Related]
11. Perioperative management of pulmonary hypertension after heart transplantation in childhood.
Bauer J; Dapper F; Demirakça S; Knothe C; Thul J; Hagel KJ
J Heart Lung Transplant; 1997 Dec; 16(12):1238-47. PubMed ID: 9436136
[TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
[TBL] [Abstract][Full Text] [Related]
13. Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients.
Alba AC; Rao V; Ross HJ; Jensen AS; Sander K; Gustafsson F; Delgado DH
J Heart Lung Transplant; 2010 Nov; 29(11):1253-8. PubMed ID: 20620083
[TBL] [Abstract][Full Text] [Related]
14. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.
Erickson KW; Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Zucker MJ; Pifarré R; Lawless CE; Robinson JA; Scanlon PJ
J Heart Transplant; 1990; 9(5):526-37. PubMed ID: 2231091
[TBL] [Abstract][Full Text] [Related]
15. [Special anesthesia care in heart transplantation. The management of right ventricular failure].
Gómez-Arnau J; Planas A; Lora-Tamayo JI; Martínez MV
Rev Esp Cardiol; 1995; 48 Suppl 7():60-4. PubMed ID: 8775818
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance.
Kannan BR; Sivasankaran S; Tharakan JA; Titus T; Ajith Kumar VK; Francis B; Krishnamoorthy KM; Harikrishnan S; Padmakumar R; Nair K
Indian Heart J; 2003; 55(2):161-6. PubMed ID: 12921332
[TBL] [Abstract][Full Text] [Related]
17. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
18. Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension.
Chen EP; Bittner HB; Davis RD; Van Trigt P
Ann Thorac Surg; 1997 Jun; 63(6):1546-55. PubMed ID: 9205146
[TBL] [Abstract][Full Text] [Related]
19. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
Frigerio M; Gronda E; Danzi GB; Mangiavacchi M; Oliva F; Quaini E; Trotta E; De Vita C; Pellegrini A
G Ital Cardiol; 1995 Jan; 25(1):1-9. PubMed ID: 7642005
[TBL] [Abstract][Full Text] [Related]
20. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
